Interestingly, the percentage of ITGAV+ cancer cells initially increased within the EpCAMlow population of mixed cSCCs, this marker being highly expressed in the mesenchymal cancer cells (Fig. 1F). The gene discussed is ITGAV; the disease is cancer.